SD
Sartorius Stedim Biotech S.A.
SDMHF · OTC
$223.75 +0.34% (+$0.75)
1M -2.29%
Market Cap 18.9B €
P/E Ratio 64.54x
Div. Yield 0.36%
ROE 7.11%
Bulios Fair Price
$111.92
50.0% downside
Current Price
$223.75
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SDMHF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
26 /100
Expensive EV/EBITDA 14.50x
P/S 6.28x
P/B 4.47x
Growth
10 /100
Declining Rev. growth 5.30%
FCF growth 7.17%
Book val. growth 18.63%
Profitability
69 /100
Strong Net margin 9.74%
Op. margin 18.59%
FCF margin 7.33%
Quality
32 /100
Poor ROE 7.11%
ROA 3.70%
Asset turnover 0.38x
Debt
70 /100
Low Current ratio 1.16x
Int. coverage 6.31x
Net debt/EBITDA 1.51x
Stability
61 /100
Moderate Rev. volatility 14.22%
EPS volatility 62.03%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SDMHF
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Rene Faber
Employees
10,265
Headquarters
Aubagne
Upcoming events
22 OCT
Earnings
Upcoming earnings report